Literature DB >> 31758800

The Patient Perspective: Putting the Patient at the Center of the Translational Innovation Process.

Leslie Wilson1, Lawrence Lin2, Kuldev Singh3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31758800      PMCID： PMC9426754          DOI： 10.1002/cpt.1686

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.903


× No keyword cloud information.
  9 in total

1.  A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy.

Authors:  Holly L Peay; Ilene Hollin; Ryan Fischer; John F P Bridges
Journal:  Clin Ther       Date:  2014-05       Impact factor: 3.393

2.  Information Patients Can Provide Will Strengthen the Real-World Evidence That Matters to Them.

Authors:  W Benjamin Nowell
Journal:  Clin Pharmacol Ther       Date:  2019-05-21       Impact factor: 6.875

3.  Caregiver preferences for emerging duchenne muscular dystrophy treatments: a comparison of best-worst scaling and conjoint analysis.

Authors:  Ilene L Hollin; Holly L Peay; John F P Bridges
Journal:  Patient       Date:  2015-02       Impact factor: 3.883

4.  Incorporating patient-preference evidence into regulatory decision making.

Authors:  Martin P Ho; Juan Marcos Gonzalez; Herbert P Lerner; Carolyn Y Neuland; Joyce M Whang; Michelle McMurry-Heath; A Brett Hauber; Telba Irony
Journal:  Surg Endosc       Date:  2015-01-01       Impact factor: 4.584

5.  Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective.

Authors:  F Reed Johnson; Mo Zhou
Journal:  Value Health       Date:  2016 Sep - Oct       Impact factor: 5.725

6.  Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy.

Authors:  F Reed Johnson; George Van Houtven; Semra Ozdemir; Steve Hass; Jeff White; Gordon Francis; David W Miller; J Theodore Phillips
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

7.  Patient centered decision making: use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices.

Authors:  Leslie Wilson; Aimee Loucks; Christine Bui; Greg Gipson; Lixian Zhong; Amy Schwartzburg; Elizabeth Crabtree; Douglas Goodin; Emmanuelle Waubant; Charles McCulloch
Journal:  J Neurol Sci       Date:  2014-06-23       Impact factor: 3.181

8.  A discrete choice experiment to determine patient preferences for injection devices in multiple sclerosis.

Authors:  S L Shingler; P Swinburn; S Ali; R Perard; A J Lloyd
Journal:  J Med Econ       Date:  2013-06-12       Impact factor: 2.448

9.  Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.

Authors:  Christine Poulos; Elizabeth Kinter; Jui-Chen Yang; John F P Bridges; Joshua Posner; Anthony T Reder
Journal:  Patient       Date:  2016-04       Impact factor: 3.883
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.